Stock Movers

On this episode of Stock Movers:- BP said it expects to take as much as $5 billion in writedowns for the fourth quarter, just weeks after replacing its chief executive officer as it strives to turn around its fortunes.- Goldman favors asset-light exposure in global logistics with analyst Patrick Creuset cutting hit recommendation on Maersk to sell.- Vistry sold 9% fewer homes in 2025 after uncertainty driven by the UK budget created a “subdued market” in the second half of the year.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- JPMorgan Chase (JPM) fell 4.2%. The bank's profit declined 7% in the fourth quarter, even as revenue rose on the back of higher fees and interest income. This after JPMorgan warned that President Donald Trump’s call for a 10% cap on credit card rates threatens to “significantly change” its business and would harm the biggest US bank and customers.- Meta Platforms (META) is beginning to cut more than 1,000 jobs from the company’s Reality Labs division, part of a plan to redirect resources from virtual reality and metaverse products toward AI wearables and phone features. Meta shares closed at 1.69%- Delta Air Lines (DAL) provided a profit forecast that fell short of Wall Street estimates, with the major US airline taking a more cautious view for 2026 after the aviation industry emerged from a volatile year. Shares in Atlanta-based Delta fell 1.5% to $70 as of 11:07 a.m. New York time after it reported quarterly results on Tuesday. United Airlines was up fractionally, while American Airlines fell 1.7%See omnystudio.com/listener for privacy information.

On this episode of Stock Movers: - Meta Platforms (META) shares fall after news that Meta Platforms Inc. and EssilorLuxottica SA are discussing potentially doubling production capacity for AI-powered smart glasses by the end of this year to capture growing demand and head off rivals. - Delta Airlines (DAL) shares fall after the company provided a profit forecast that fell short of Wall Street estimates, suggesting the major US airline is taking a more cautious view for 2026 after the aviation industry emerged from a volatile year. - L3Harris Technologies (LHX) shares rise after news that the US Department of Defense is set to invest in L3Harris Technologies Inc.'s missile unit with a $1 billion convertible preferred security. The investment will "significantly" increase capacity to build solid rocket motors for US missiles, according to L3Harris.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- JPMorganChase (JPM) shares are up after earnings. The firm expects to earn about $103 billion in net interest income this year, more than analysts expected, and said the US economy has remained resilient with consumers continuing to spend and businesses generally remaining healthy.- Delta Airlines (DAL) shares fall after the company provided a profit forecast that fell short of Wall Street estimates, suggesting the major US airline is taking a more cautious view for 2026 after the aviation industry emerged from a volatile year. - Alphabet (GOOGL) shares rise as analysts for both Apple and Alphabet are positive on the news that Alphabet’s Google has entered multiyear deal to power the iPhone maker’s AI technology, including its Siri digital assistant.See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:- Delta Air Lines (DAL) is ordering 30 Boeing Co. 787 Dreamliner jets in its first-ever purchase of that model, providing a boost to the US planemaker that highlights the airline’s optimism for international travel demand.The announcement came as Atlanta-based Delta reported earnings for the fourth quarter that beat analyst estimates. Revenue last year rose to a record $58.3 billion, in line with analysts’ expectations, it said on Tuesday- L3Harris (LHX) shares gain after the contractor said the Department of Defense is set to invest in its Missile Solutions business through a $1 billion convertible preferred security, which would automatically convert into common equity upon the unit’s planned IPO.- Travere Therapeutics (TVTX) slumps after the biotech firm said it received a request from the FDA to clarify the clinical benefit of its therapy that treats a rare kidney disease, a move that analysts said could delay the approval by the agency.See omnystudio.com/listener for privacy information.